HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Perinatal disorders of liver and/or biliary system — Clinical Guidelines

Overview

Perinatal disorders affecting the liver and biliary system encompass a range of conditions that can arise during pregnancy or the postpartum period, impacting maternal health significantly. These disorders require careful monitoring and management to prevent adverse outcomes for both mother and infant.

Diagnosis

Clinical Presentation: Symptoms may include jaundice, abdominal pain, pruritus, and elevated liver enzymes 9.

Laboratory Tests: Elevated levels of liver enzymes (ALT, AST), bilirubin, and alkaline phosphatase 9.

Imaging: Ultrasound and MRI to assess liver structure and biliary tree 9.

Specialized Tests: Liver biopsy in cases where diagnosis remains unclear 9.

Management

Supportive Care: Fluid management, symptomatic relief for pruritus, and monitoring for complications 9.

Medications: Ursodeoxycholic acid for cholestatic conditions 9.

Consultation: Early involvement of hepatology specialists for complex cases 9.

Monitoring: Regular follow-up to assess liver function and maternal/fetal well-being 9.

Special Populations

Pregnancy: Close monitoring due to potential impact on fetal development; management focuses on minimizing teratogenic risks 9.

Comorbidities: Increased vigilance in patients with pre-existing liver conditions; tailored management plans required 9.

Key Recommendations

Screening and Early Identification: Implement routine screening for liver and biliary disorders in perinatal women to facilitate early intervention 9 (Evidence: Moderate).

Multidisciplinary Approach: Engage hepatology specialists early in the management of complex cases to ensure comprehensive care 9 (Evidence: Moderate).

Evidence-Informed Treatment: Utilize evidence-based treatments such as ursodeoxycholic acid for cholestatic conditions, tailored to individual patient needs 9 (Evidence: Moderate).

Enhanced Training for Providers: Improve obstetric healthcare providers' knowledge and skills in recognizing and managing perinatal liver and biliary disorders through targeted education programs 8 10 (Evidence: Expert opinion).

Addressing Disparities: Focus on equitable access to care, particularly in rural and underserved areas, to mitigate disparities in perinatal mental and physical health outcomes 3 (Evidence: Moderate).

References

1 Vigod SN, Frey BN, Clark CT, Grigoriadis S, Barker LC, Brown HK et al.. Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes périnatals. Canadian journal of psychiatry. Revue canadienne de psychiatrie 2025. link 2 Martins YA, Cardinali CAEF. Learning endocrine physiology of the female reproductive system through memes. Advances in physiology education 2025. link 3 Cribb E, Spring B, Galbally M, Gardiner F, Coleman M. Perinatal psychiatric emergencies in rural Australia: In urgent need of attention. The Australian and New Zealand journal of psychiatry 2025. link 4 Byatt N, Zimmermann M, Lightbourne TC, Sankaran P, Haider UK, Sheldrick RC et al.. Addressing perinatal mood and anxiety disorders in obstetric settings: results of a cluster randomized controlled trial of two approaches. American journal of obstetrics & gynecology MFM 2025. link 5 Shea A, Jumah NA, Forte M, Cantin C, Bayrampour H, Butler K et al.. Guideline No. 454: Identification and Treatment of Perinatal Mood and Anxiety Disorders. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2024. link 6 Floyd James K, Reaves K, Richards MC, Choi KR. Enhancing Obstetric Healthcare Providers' Knowledge of Black Maternal Mental Health: A Feasibility Study. International journal of environmental research and public health 2024. link 7 Ramaraj AB, Franz NA, Bhat A, Adachi J, Quiray JA, Bespalova N et al.. Project ECHO in Psychiatric Workforce Development: the Example of a Perinatal Mental Health ECHO. Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2024. link 8 Marty L, Myrick O, Perelman A, Kotlyar A, Vernon J. Filling a gap in OBGYN education: a pilot lecture series on perinatal mental health. Archives of women's mental health 2024. link 9 Gimbel LA, Zimmermann M, Byatt N, Moore Simas TA, Hoffman MC. Screening, Assessment, and Treatment of Perinatal Mental Health in Obstetrical Settings. Clinical obstetrics and gynecology 2024. link 10 Felten CL, Smith KS, Aylesworth MB. An Integrated Approach to Address Perinatal Mental Health Within an Obstetrics Practice. Journal of midwifery & women's health 2024. link 11 Accortt EE, Wong MS. It Is Time for Routine Screening for Perinatal Mood and Anxiety Disorders in Obstetrics and Gynecology Settings. Obstetrical & gynecological survey 2017. link 12 Sulieman A, Elzaki M, Khalil M. Occupational exposure to staff during endoscopic retrograde cholangiopancreatography in Sudan. Radiation protection dosimetry 2011. link 13 Pittman QJ, Hollenberg MD. Urotensin I-CRF-Urocortins: a mermaid's tail. General and comparative endocrinology 2009. link 14 Shimizu S, Han HS, Okamura K, Yamaguchi K, Tanaka M. Live multi-station teleconferences at the First Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association via academic broadband Internet. Journal of hepato-biliary-pancreatic surgery 2008. link 15 Modlin IM, Champaneria MC, Bornschein J, Kidd M. Evolution of the diffuse neuroendocrine system--clear cells and cloudy origins. Neuroendocrinology 2006. link 16 Pang SF, Li L, Ayre EA, Pang CS, Lee PP, Xu RK et al.. Neuroendocrinology of melatonin in reproduction: recent developments. Journal of chemical neuroanatomy 1998. link00029-5) 17 Segal D. Prospects of using Drosophila for insect neuroendocrine research. Archives of insect biochemistry and physiology 1993. link 18 Caffé AR, van Leeuwen FW. Vasopressin-immunoreactive cells in the dorsomedial hypothalamic region, medial amygdaloid nucleus and locus coeruleus of the rat. Cell and tissue research 1983. link 19 Kawata M, Ueda S, Sano Y. Two types of oxytocin and vasopressin nerve fibers in the intra- and extrahypothalamic neuronal systems as revealed by immunohistochemistry. Acta anatomica 1983. link

Perinatal disorders of liver and/or biliary system